Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Delgocitinib wo patent synthesis?Current street price of adderall 2026?Tetrabenazine vs austedo?Pindolol generic name?Tretinoin cream 0 5 price in bangladesh?
See the DrugPatentWatch profile for Linzess
As of late 2023, there is no generic version of Linzess (linaclotide) available in the United States [1].
The patent exclusivity for Linzess is set to expire. DrugPatentWatch.com tracks these expiration dates, and information suggests that key patents for Linzess may begin to expire in the coming years, potentially paving the way for generic competition [1]. However, the exact timeline can be influenced by various factors, including patent challenges and regulatory approvals.
The availability of a generic version of Linzess would likely lead to lower drug costs for patients and healthcare systems [2]. Generic medications are typically priced at a significant discount compared to their brand-name counterparts. This increased accessibility could improve treatment adherence for individuals managing conditions like irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) [3].
Linzess is manufactured by Ironwood Pharmaceuticals and its collaborator, AbbVie [4].
Linzess is a prescription medication used to treat adults with irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) [3]. It works by increasing fluid secretion in the intestines, which helps to speed up the passage of stool [3].
Other Questions About Linzess :